会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Specific lipid conjugates to nucleoside diphosphates and their use as drugs
    • 特异性脂质偶联物与核苷二磷酸及其作为药物的用途
    • US06372725B1
    • 2002-04-16
    • US09204497
    • 1998-12-04
    • Harald ZilchDieter Herrmann
    • Harald ZilchDieter Herrmann
    • A61K3170
    • C07H19/10C07H19/207
    • The present invention concerns new phospholipid derivatives of nucleosides of the general formula (I) in which R1 represents a straight-chained or branched, saturated or unsaturated aliphatic residue with 9-14 carbon atoms which can optionally be substituted once or several times; R2 can represent a straight-chained or branched, saturated or unsaturated aliphatic residue with 8-12 carbon atoms which can optionally be substituted once or several times; m is 2 or 3; A can represent a methylene group or an oxygen; Nuc can be a nucleoside or a residue derived from a nucleoside derivative; and tautomers thereof and their physiologically tolerated salts of inorganic and organic acids and bases as well as pharmaceutical preparations containing these compounds.
    • 本发明涉及通式(I)的核苷的新型磷脂衍生物,其中R 1表示具有9-14个碳原子的直链或支链,饱和或不饱和的脂肪族残基,其可任选被取代一次或数次; R2可以表示具有8-12个碳原子的直链或支链,饱和或不饱和的脂肪族残基,其可任选被取代一次或数次; m为2或3; A可以表示亚甲基或氧; Nuc可以是衍生自核苷衍生物的核苷或残基; 及其互变异构体及其生理上耐受的无机和有机酸和碱的盐以及含有这些化合物的药物制剂。
    • 9. 发明授权
    • Lipid alcohols as new immunosuppressive and antiviral drugs
    • 脂质醇作为新的免疫抑制和抗病毒药物
    • US06177469B1
    • 2001-01-23
    • US09051088
    • 1998-06-22
    • Harald ZilchDieter HerrmannHans-Georg Opitz
    • Harald ZilchDieter HerrmannHans-Georg Opitz
    • A61K3700
    • C07C323/25A61K31/08A61K31/10C07C317/18
    • The present invention concerns new immunosuppressive and antiviral pharmaceutical agents using lipid alcohols of the general formulae I and II in which R1 represents a straight-chained or branched, saturated or unsaturated alkyl chain with 1-30 carbon atoms which can optionally be substituted once or several times by halogen, C1-C6 alkoxy, C1-C6 alkylmercapto, C1-C6 alkoxycarbonyl, carboxy, C1-C6 alkylsulfinyl or C1-C6 alkylsulfonyl groups, R2 represents hydrogen, a straight-chained or branched, saturated or unsaturated alkyl chain with 1-20 carbon atoms which can optionally be substituted once or several times by halogen, C1-C6 alkoxy, C1-C6 alkylmercapto, C1-C6 alkoxycarbonyl or C1-C6 alkylsulfonyl groups, X represents a valency dash, oxicarbonyl, carbonyloxy, amidocarbonyl, carbonylamido, oxygen, sulphur, a sulfinyl or sulfonyl group Y represents a valency dash, oxicarbonyl, carbonyloxy, amidocarbonyl, carbonylamido, oxygen, sulphur, a sulfinyl or sulfonyl group n represents an integer value from 1 to 5 inclusive as well as tautomers thereof and combinations containing these compounds with other active substances.
    • 本发明涉及新的免疫抑制和抗病毒药物,其使用通式I和IIin的脂质醇,其中R1表示具有1-30个碳原子的直链或支链,饱和或不饱和的烷基链,其可以任选被一次或多次取代一次或几次 卤素,C 1 -C 6烷氧基,C 1 -C 6烷基巯基,C 1 -C 6烷氧基羰基,羧基,C 1 -C 6烷基亚磺酰基或C 1 -C 6烷基磺酰基,R 2表示氢,直链或支链,饱和或不饱和的具有1-20 碳原子,其可任选被卤素,C 1 -C 6烷氧基,C 1 -C 6烷基巯基,C 1 -C 6烷氧基羰基或C 1 -C 6烷基磺酰基取代一次或几次,X表示化合价,氧羰基,羰基氧基,酰氨基羰基,羰基酰氨基,氧 ,硫,亚磺酰基或磺酰基Y表示化合价,氧羰基,羰氧基,酰氨基羰基,羰基酰氨基,氧,硫,亚磺酰基或磺酰基,代表整数va 从1到5,以及其互变异构体和含有这些化合物与其它活性物质的组合。